stella
beta
Chemotherapy-free Regimen of Venetoclax, Azacitidine Plus Orebatinib (VAO Regimen) for Newly Diagnosed ph+ALL — Stella
Recruiting
Back to Ph-Positive Acute Lymphoblastic Leukemia trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu
View full record on ClinicalTrials.gov